SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-034072
Filing Date
2024-08-27
Accepted
2024-08-27 19:55:48
Documents
1
Period of Report
2024-08-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3978
  Complete submission text file 0001493152-24-034072.txt   5519
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Issuer) CIK: 0001958777 (see all company filings)

IRS No.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1651 NORTH BEVERLY DRIVE BEVERLY HILLS CA 90210
Business Address
Niklas Victoria Ninon Olivia (Reporting) CIK: 0002012250 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41934 | Film No.: 241250663